Quick summary: Perimenopause is the hormonal transition leading up to menopause, typically lasting several years and marked by irregular cycles and fluctuating estrogen. Menopause is confirmed after 12 consecutive months without a period. Most women do not need hormone tests to diagnose either stage — symptoms and cycle history are usually enough. When symptoms are moderate to severe, hormone replacement therapy (HRT) is the most effective treatment for hot flashes and night sweats, with a benefit-risk profile that is generally most favorable when started before age 60. A consultation with a qualified provider helps determine whether HRT is appropriate for your specific history.
Medically reviewed by the clinical team at OC Weight Loss & Med Spa. Last updated: June 12, 2026.
What these terms actually mean
Perimenopause is the transition leading up to menopause, marked by irregular cycles as ovarian hormone production becomes erratic. Menopause itself is diagnosed after 12 consecutive months without a period. In early perimenopause, cycles often shorten; later, gaps of 60 days or more are common before bleeding stops altogether. The average age of menopause in the U.S. is about 51.
At-a-glance comparison
Symptoms you might notice
Vasomotor symptoms — hot flashes and night sweats — affect a large share of midlife women. Sleep disruption, brain fog, mood changes, and vaginal dryness or discomfort may appear during the transition and persist to varying degrees after periods end. Cycle unpredictability itself is a recognizable sign of perimenopause.
Do you need hormone testing?
Most women do not need routine hormone panels to confirm perimenopause or menopause. Follicle-stimulating hormone (FSH) and estradiol levels fluctuate widely in the 40s and early 50s and are not reliable single-point diagnostics. Clinicians typically diagnose based on age, cycle pattern, and symptoms, while ordering targeted tests only to rule out other causes when needed — for example, pregnancy, thyroid dysfunction, or elevated prolactin. Over-the-counter FSH tests sold as “menopause tests” are of limited diagnostic value for the same reason.
Nonhormonal relief options
Several nonhormonal strategies can meaningfully reduce symptoms. Behavioral approaches — cooling techniques, sleep hygiene, paced respiration, and cognitive behavioral therapy for menopause — are reasonable first steps. For prescription medication, the FDA approved fezolinetant (Veozah) in May 2023 specifically for moderate-to-severe hot flashes; it works by blocking the NK3 receptor in the brain’s temperature-regulation pathway. Because rare liver effects have been observed, the prescribing label requires liver function tests before starting and every three months during the first nine months of use. Certain SSRIs, SNRIs, and gabapentin are additional options when hormonal therapy is not appropriate.
When to consider hormone replacement therapy
When symptoms are moderate to severe or disrupt daily life, systemic estrogen — combined with a progestogen for anyone with a uterus — remains the most effective treatment for hot flashes and night sweats. It also helps protect against bone loss and fractures. The benefit-risk profile of hormone replacement therapy is generally most favorable when started before age 60 or within 10 years of menopause. Transdermal delivery (patch, gel, or spray) and lower doses may reduce certain risks, including venous thromboembolism and stroke, compared with oral estrogen in some patients. Individual contraindications are significant: a history of estrogen-sensitive cancer, active liver disease, unexplained vaginal bleeding, prior blood clots, stroke, or heart attack all affect candidacy. Shared decision-making and periodic reevaluation are central to safe use.
What HRT is not intended for
Systemic hormones are not recommended as a strategy to prevent heart disease or dementia in otherwise well, asymptomatic individuals. That reflects the U.S. Preventive Services Task Force position and is consistent with the balance of benefits and harms seen in large randomized trials. Bone and cardiovascular prevention should continue through standard evidence-based measures based on each person’s individual risk profile.
Local therapies, pellets, and a note on compounded products
If vaginal dryness, pain with intercourse, or urinary symptoms are the primary concerns, low-dose vaginal estrogen and other local options can generally be used at any age and for extended periods. Evidence suggests this approach may be appropriate even for some cancer survivors after nonhormonal measures have been tried, with oncology input. If you are considering pellet therapy, it is worth asking whether an FDA-approved HRT formulation could meet your goals first. Compounded bioidentical hormone products, including some pellets, are not FDA-approved, lack consistent potency data, and are not routinely recommended by major medical organizations.
Safety, side effects, and who should not use HRT
Hormone therapy carries real risks that vary by formulation, dose, route, and individual health history. Common side effects include breast tenderness, bloating, headaches, and spotting in early use. More significant risks — including venous thromboembolism, stroke, and in certain populations breast cancer — inform the decision to use systemic therapy and the choice of route. FDA-approved transdermal formulations carry a lower clot risk than oral estrogen in most studies. HRT is generally not appropriate for people with a personal history of hormone-sensitive cancers, unexplained vaginal bleeding, active liver disease, or prior cardiovascular events. Candidacy is determined at consultation by the medical provider based on a full review of your health history, current symptoms, and goals. Individual results vary.
Frequently asked questions
How do I know if I’m in perimenopause or menopause?
Perimenopause is identified by irregular menstrual cycles combined with symptoms like hot flashes, sleep changes, or mood shifts — typically beginning in the mid-to-late 40s. Menopause is confirmed only after 12 consecutive months without a period. A clinician can help distinguish the two based on your symptom history and cycle pattern; hormone blood tests are rarely the deciding factor.
Is HRT safe?
For most healthy women under 60 who are within 10 years of menopause and have moderate-to-severe symptoms, the benefits of HRT typically outweigh the risks. Risk profile varies significantly by formulation, delivery route, dose, and personal health history. A thorough consultation with a qualified provider is the appropriate way to assess whether HRT is right for your situation.
What is the difference between bioidentical and conventional HRT?
“Bioidentical” refers to hormones that are chemically identical to those produced by the body. Several FDA-approved HRT products are bioidentical in this sense. Compounded bioidentical products — often marketed as custom-mixed — are not FDA-approved and have not been shown to be safer or more effective than approved formulations. Major medical organizations recommend FDA-approved options as first-line treatment.
How long does perimenopause last?
The perimenopause transition typically lasts four to eight years, though this varies widely. Some women experience it for only a year or two; others notice hormonal symptoms for more than a decade before reaching menopause. Symptom intensity and duration are highly individual.
Do I need to stop HRT at a certain age?
There is no universal age cutoff. The decision to continue or taper HRT is made on an individual basis through shared decision-making with your provider, typically reviewed annually. For some women, vasomotor symptoms return when HRT is discontinued, which factors into the conversation. The goal is the lowest effective dose for the shortest duration that meets your clinical needs.
Take the next step
If you are navigating perimenopause or menopause and want guidance on your options — from nonhormonal strategies to FDA-approved HRT — the clinical team at OC Weight Loss & Med Spa in Mission Viejo can help. Lindsay Short, NP provides individualized hormone consultations in a supervised, evidence-based practice. Book a free consultation to review your symptoms and explore what is appropriate for your health history.
Book a free consultation
Book a Free Consultation